Uterine fibroids are noncancerous growths that develop in the muscle wall of the uterus. They can vary in size from very tiny to larger than a cantaloupe. A woman can have more than one fibroid in the uterus. Uterine fibroids do not always cause symptoms or require treatment. However, they can cause heavy, prolonged, painful menstrual periods; leg, back, and pelvic pain; painful intercourse; pelvic pressure or heaviness; abdominal swelling; pressure on the bowels leading to constipation and bloating; and pressure on the bladder leading to a constant urge to urinate. Uterine fibroids may prevent a woman from becoming pregnant.
Uterine artery embolization (UAE), also called transcatheter UAE, is a nonsurgical treatment that shrinks fibroids. The procedure is done in same day surgery and does not require an overnight stay unless there are complications. An interventional radiologist or x-ray physician performs the procedure. A tube or catheter is inserted into an artery in the upper leg. This tube is threaded through the artery toward the uterus, which is located in the abdomen. After the tube reaches the uterine artery, a dye is injected. The dye helps the physician see the blood vessels with an x-ray machine. Next the physician injects tiny balls the size of sand that are made of plastic or gelatin sponge. These balls block the blood supply to the fibroids causing them to shrink and die. The procedure might be repeated on the other side of the body so the blood supply is blocked in both the right and left uterine arteries.
Will I live longer if I have this procedure?
Yes, if you are having the procedure as a life-saving measure or for uncontrolled bleeding due to uterine fibroids, you may live longer.
Will the treatment of uterine fibroids improve my quality of life?
Yes, this procedure may relieve serious problems that interfere with normal functions. It might be an option for women who have failed or who cannot use medical therapy, who wish to avoid surgery, or who should not have surgery for a medical reason. This procedure also maintains normal ovary and hormonal function.
Does the treatment of uterine fibroids make my symptoms better?
Yes, available data suggest that UAE offers some relief from the major symptoms of fibroids for about 8 in 10 women undergoing the procedure. However, about 1 in 4 women might need an additional procedure within two to five years. A woman might be able to get pregnant after this procedure although she is at risk for pregnancy-related complications, such as premature delivery, cesarean delivery, or hemorrhage.
The Society of Cardiovascular and Interventional Radiology documented 25,000 uterine artery embolization procedures as of the year 2001. Of these, there were four deaths reported as a result of complications.
How safe is this procedure for me?Before a uterine artery embolization, an adequate evaluation and diagnosis of your problem is necessary. Symptoms like pelvic pain or unusual bleeding may not be related to problems with the uterus. If the uterus is not causing your pain, uterine artery embolization may not relieve the pain. The pain may be due to problems in your digestive, urinary, or skeletal system.
The American College of Obstetricians and Gynecologists' Committee on Gynecologic Practice considers this procedure investigational or relatively contra-indicated in women wishing to have children. The Committee also strongly recommends that women who wish to undergo uterine artery embolization have a thorough evaluation with an obstetrician-gynecologist. This will provide more information for the physician and the radiologists, and will help to ensure that this is the best therapy for you. The physicians will also need to discuss plans for future pregnancies with you.
Minor reported complications:
Major reported complications:
Uterine artery embolization is not recommended if any of the following conditions exist:
Alternative treatments include:
There are several ways to perform a myomectomy. Surgery with a hysteroscope is one method, with the fibroids removed vaginally. Surgery with a laparoscope is another, with the fibroids removed through a small abdominal incision. Surgery can also be done through a larger abdominal incision.

| Procedure | Typical charges |
|
Uterine artery embolization |
$3,200 to $4,500 |
|
Hormone therapy |
$50 to $1,700 for a three month supply |
|
Hysterectomy |
$5,000 to $6,000 |
|
Myomectomy with a hysteroscope |
$4,060 |
|
Myomectomy with alaparoscope |
$4,080 |
|
Abdominal myomectomy |
$4,500 |
Watching and waiting is the least expensive means of dealing with uterine fibroids. The only cost may be the co-payment for the office visit.
The cost may or may not be covered by your health benefits plan.
The following are off-site links
:
Agency for Healthcare Research and Quality. (2001). Evidence report assessment: Number 34, Management of uterine fibroids. Retrieved June 10, 2008 from http://www.ahrq.gov/clinic/epcsums/utersumm.htm.
American College of Obstetricians and Gynecologists. (2004, January). ACOG News Release: ACOG issues opinion on uterine artery embolization for treatment of fibroids. Retrieved June 10, 2008 fromhttp://www.acog.org/from_home/publications/press_releases/nr01-30-04-2.cfm.
American College of Radiology. (2008, March). Uterine fibroid embolization (UFE). Retrieved June 10, 2008from http://radiologyinfo.org/en/pdf/ufe.pdf.
National Uterine Fibroids Foundation. (2004, August). About uterine fibroids. Treatments. Retrieved June 10, 2008 from http://www.nuff.org/health_treatments.htm.
Society of Interventional Radiologist. (2008). Uterine fibroids symptoms, diagnosis and treatment. Retrieved June 10, 2008 from http://www.sirweb.org/patPub/uterine.shtml.
U. S. Food and Drug Administration (2002, November). Center for Devices and Radiological Health. 510 (k) summary for embosphere® microspheres for use in uterine fibroid embolization. Retrieved June 10, 2008 from http://www.fda.gov/cdrh/pdf2/k021397.pdf.
U. S. Food and Drug Administration. (2002, November). FDA Talk Paper. FDA clears device to treat fibroids. Retrieved June 10, 2008 from http://www.fda.gov/bbs/topics/ANSWERS/2002/ANS01175.html.
06/10/2009
This document has been classified as public information.